Respiratory syncytial virus vaccine oral (Vaxart)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameRespiratory syncytial virus vaccine oral (Vaxart)
Drug Alias NameRSV tablet vaccineVXA-RSV-f oral vaccineVXA-RSV-f
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulantsToll like receptor 3 agonists
TargetsToll like receptor 3
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVaxart Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVaxart Inc
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A